BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Programmed cell death 1 (PD-1; PDCD1; CD279); asparagine-linked glycosylation 8 (ALG8); laminin α subunit 4 (LAMA4); ADP-dependent glucokinase (AD

February 5, 2015 8:00 AM UTC

Two studies in mice suggest tumor vaccines based on tumor-specific mutant antigens could help improve the efficacy of therapies targeting PD-1 and other checkpoint inhibitors. In a mouse model of anti...